Spruce Biosciences GAAP EPS of -$8.51 misses by $2.83
At a glance
- $SPRB today−2.45%last $42.25
- Vs industry peers−2.39 pts6-peer median −0.06% · far behind
- Since Nov 9+5.63%from the first trade after the story
- 52-week range11.0% above low$38.06 – $127.90
- Cash runway~18 mo$87.7M cash ÷ $5.0M/mo burn · 10-Q
- In the headline$8.51Amount
Nothing reported about spruce biosciences across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: This one turns on a concrete figure ($8.51); set it against the recent trend before reading it as a turning point.
- How the stock is trading: $SPRB -2.45% in the latest session.
- Timing: It came out pre-market, so the next session was the first that could react.
Where the stock stands
Spruce Biosciences ($SPRB) fell 2.45% to $42.25 in the latest session. Over the past month it is up 4.6%. That leaves it 67% below its 52-week high of $127.90 and 11% above its low of $38.06, close to the bottom of its range. The year's high was 3.4 times its low, which makes double-digit swings fairly routine here.
What the filings say
In its latest report (10-Q, filed Nov 9, 2026), $SPRB lost $24.0M over the quarter to Sep 30, 2026. Operations used $44.6M of cash over the nine months to Sep 30, 2026 — about $5.0M a month — against $87.7M in cash on Sep 30, 2026. At that pace the cash covers about 18 months. It carried $7.8M of debt against $87.7M of cash on Sep 30, 2026 — net cash of $79.9M. The company filed an 8-K — the form for material events — on Nov 9, the same day as this story; it is $SPRB's own account and the first thing to read. Figures are as filed with the SEC; the $SPRB page has the full statements.
How much coverage it is getting
Wook has no other story on Spruce Biosciences from the last 30 days, so there is no recent run to compare this one with.
The bigger picture
With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.
What to watch next
The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $SPRB page, and they say what management has disclosed without a reporter in between. Where several outlets agree is usually the news; where they differ is the angle. Wook AI, at the top of the page, can work out how far $SPRB is from its high or compare this week's coverage with earlier weeks.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on November 9, 2026. $SPRB has moved +5.63% ($40.00 to $42.25). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
